Thermo Fisher Scientific (TMO) Cash from Discontinued Operations (2009 - 2017)
Thermo Fisher Scientific's (TMO) quarterly Cash from Discontinued Operations came in at $1.0 million in Q4 2017, little changed on a YoY basis from $1.0 million in Q4 2016, and up 200.0% quarter-over-quarter from -$1.0 million in Q3 2017.
Analysis
Thermo Fisher Scientific (TMO) Cash from Discontinued Operations (2009 - 2017) Analysis & Trends
Thermo Fisher Scientific (TMO) has reported Cash from Discontinued Operations for 9 consecutive years, with $1.0 million the latest figure, recorded in Q4 2017.
- For the quarter ending Q4 2017, Cash from Discontinued Operations changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2018 stood at $1.0 million (up 200.0% YoY), and the FY2017 full-year result was -$1.0 million, up 50.0% from the prior year.
- Cash from Discontinued Operations advanced to $1.0 million in Q4 2017 per TMO's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at $1.0 million in Q4 2016 and bottomed at -$3.7 million in Q3 2015.
- Historically, Cash from Discontinued Operations has averaged -$1.1 million across 5 years, with a median of -$1.0 million in 2014.
- The sharpest annual moves came in 2015 and 2016: Cash from Discontinued Operations plunged 144.44% in 2015, then soared 200.0% in 2016.
- Over 5 years, Cash from Discontinued Operations stood at -$1.6 million in 2013, then soared by 50.0% to -$800000.0 in 2014, then slipped by 25.0% to -$1.0 million in 2015, then jumped by 200.0% to $1.0 million in 2016, then changed by 0.0% to $1.0 million in 2017.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered $1.0 million, -$1.0 million, and -$1.0 million for Q4 2017, Q3 2017, and Q2 2017 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 1.00 Mn |
| Sep 30, 2017 | -1.00 Mn |
| Apr 1, 2017 | -1.00 Mn |
| Dec 31, 2016 | 1.00 Mn |
| Oct 1, 2016 | -1.10 Mn |
| Jul 2, 2016 | -400,000.00 |
| Apr 2, 2016 | -1.50 Mn |
| Dec 31, 2015 | -1.00 Mn |
| Sep 26, 2015 | -3.70 Mn |
| Jun 27, 2015 | -2.20 Mn |
| Mar 28, 2015 | -2.10 Mn |
| Dec 31, 2014 | -800,000.00 |
| Sep 27, 2014 | -1.60 Mn |
| Jun 28, 2014 | -900,000.00 |
| Mar 29, 2014 | -1.00 Mn |
| Dec 31, 2013 | -1.60 Mn |
| Sep 28, 2013 | -1.60 Mn |
| Jun 29, 2013 | -900,000.00 |
| Mar 30, 2013 | -800,000.00 |
| Dec 31, 2012 | -7.20 Mn |